Učitavanje...
Botulinum Toxin: An Update on Pharmacology and Newer Products in Development
Since its introduction as a treatment for strabismus, botulinum toxin (BoNT) has had a phenomenal journey and is now recommended as first-line treatment for focal dystonia, despite short-term clinical benefits and the risks of adverse effects. To cater for the high demand across various medical spec...
Spremljeno u:
| Izdano u: | Toxins (Basel) |
|---|---|
| Glavni autori: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
MDPI
2021
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7828686/ https://ncbi.nlm.nih.gov/pubmed/33466571 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/toxins13010058 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|